Farther Finance Advisors, LLC

Position in NVS — Novartis AG

CIK 1992825 SAN FRANCISCO, CA

Position in NVS

as of Jun 30, 2026 · filed Jul 17, 2026 Compact

Position Value

$5,851,924

+$579,911 QoQ

Shares Held

37,340

+8.2% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.14%

of 13F equity value

Holder Rank

#242

of 1,603 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Farther Finance Advisors, LLC holds $187,005,351 across 18 Drug Manufacturers - General names. NVS ranks #9 (3.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	43,809	$52,545,833
2	JNJ	Johnson & Johnson	135,612	$34,441,379
3	ABBV	AbbVie Inc.	119,959	$30,186,482
4	MRK	Merck & Co., Inc.	120,685	$15,508,022
5	AMGN	Amgen Inc	34,711	$12,569,547
6	PFE	Pfizer Inc	395,297	$9,518,751
7	BMY	Bristol Myers Squibb Co	148,017	$8,528,739
8	GILD	Gilead Sciences, Inc.	58,478	$7,388,110

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$5,851,924	37,340	+8.2%	Shares	Sole	2026-07-17
2026-03-31	$5,272,013	34,514	+0.4%	Shares	Sole	2026-04-07
2025-12-31	$4,739,694	34,378	+87.8%	Shares	Sole	2026-01-23
2025-09-30	$2,347,946	18,309	+5.7%	Shares	Sole	2025-10-14
2025-06-30	$2,096,861	17,328	+10.9%	Shares	Sole	2025-07-11
2025-03-31	$1,742,209	15,628	+27.7%	Shares	Sole	2025-04-14
2024-12-31	$1,190,977	12,239	-7.3%	Shares	Sole	2025-02-10
2024-09-30	$1,518,264	13,200	+25.9%	Shares	Sole	2024-10-29
2024-06-30	$1,116,020	10,483	+20.3%	Shares	Sole	2024-07-31
2024-03-31	$842,905	8,714	+18.7%	Shares	Sole	2024-05-14
2023-12-31	$741,018	7,339	+512.6%	Shares	Sole	2024-02-15
2023-09-30	$122,028	1,198	+123.5%	Shares	Sole	2023-11-14
2023-06-30	$54,087	536	-51.9%	Shares	Sole	2024-05-14
2023-03-31	$102,488	1,114	+239.6%	Shares	Sole	2024-05-14
2022-12-31	$29,756	328	—	Shares	Sole	2023-09-12
No filing history on record for this holder in this stock.